Diabetes

Mediterranean lifestyle adherence linked to lower cardiovascular events and mortality in adults with type 2 diabetes.

A nationwide Swedish study found that type 2 diabetes was associated with faster clinical progression of aortic stenosis.

A longitudinal metanalysis found significant association between the consumption of artificial sweeteners and Type 2 diabetes.

AI-led diabetes prevention drove faster engagement than human coaching, but patients rated it lower on satisfaction.

Sleeve gastrectomy was more effective than GLP-1 drugs for weight loss and glycaemic control after one year.

A study showed that the GLP-1 drug Tirzepatide has been associated with a lower risk of major adverse cardiovascular events compared with alternative treatment.

The UK has approved Eli Lilly’s Foundayo GLP-1 pill for weight loss and type 2 diabetes.

NPWT activated GRHL2 and promoted cell conversion in diabetic foot ulcers, revealing a potential mechanism underlying wound repair.